The U.S. Department of Defense Awards $1.1 Million to CytoSorbents to Optimize Development of HemoDefend-BGA(TM) for Life-saving Universal Plasma
Stock Information for CytoSorbents Corporation
Loading
Please wait while we load your information from QuoteMedia.